Diagnostic Methods for Cirrhosis and Portal Hypertension (Record no. 832)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 04143nam a22001817a 4500 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 210623b |||||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 978-3-319-72627-4 |
| International Standard Book Number | 978-3-319-72628-1 |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Annalisa Berzigotti |
| 9 (RLIN) | 15953 |
| 245 ## - TITLE STATEMENT | |
| Title | Diagnostic Methods for Cirrhosis and Portal Hypertension |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Place of publication, distribution, etc. | University of Bern Berne Switzerland |
| Name of publisher, distributor, etc. | Springer International Publishing AG, part of Springer Nature |
| Date of publication, distribution, etc. | 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 337 Pages |
| 500 ## - GENERAL NOTE | |
| General note | Includes References |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc. | The past years have witnessed an enormous advancement in all areas of hepatology,<br/>from molecular pathophysiology to diagnostic techniques and therapy, to the point<br/>that we have now effective therapies for most liver diseases and noninvasive diagnostic tests are creating new gold standards for diagnosis that before required difficult and demanding invasive techniques.<br/>These changes are paramount most especially in the diagnosis of cirrhosis and<br/>portal hypertension. We come from an era when cirrhosis was diagnosed based on<br/>liver biopsy to one when pathologists prefer to use the term “advanced chronic liver<br/>disease” instead of “cirrhosis,” thus underlining the dynamic nature of disease process. In this scenario, different disease stages are better defined on the basis of clinical, imaging, and hemodynamic characteristics than by the biopsy findings that<br/>correlate poorly with patient outcome. This is well illustrated by the fact that with<br/>similar liver biopsy findings, patient prognosis can be very good (as exemplified by<br/>the compensated patient without portal hypertension) or extremely poor (as in the<br/>case of the decompensated patient with multiple complications).<br/>The above considerations emphasize one of the major requirements in modern<br/>medicine, that is, diagnostic tests should be able to inform on prognosis, therefore<br/>providing the basis for both risk stratification at the time of diagnosis and personalizing treatment.<br/>This approach has been used to devise this book that reviews the more recent<br/>advances in the diagnostic methods for cirrhosis, the main complication of portal<br/>hypertension, and non-cirrhotic causes of portal hypertension. We are making special emphasis on new noninvasive methods and on the use of these tests in the different stages of cirrhosis and different complications of portal hypertension. After<br/>being part of the standard of care for the adult population, noninvasive diagnostic<br/>methods are increasingly used in the pediatric population with cirrhosis and/or portal hypertension, and this aspect as well as the specificities of diagnostics in Western<br/>and Eastern countries is taken into account.<br/>Our aim is to offer to the general hepatologists and hepatologists in training the<br/>current state of the art regarding the many different techniques available and under<br/>development for clinical decision making. We hope the reader will find in the different chapters of this book—all written by well-known opinion leaders in their<br/>fields—a concise but comprehensive and updated, clinically focused guide to<br/>answer difficult questions, such as when to think about rare causes of non-cirrhotic |
| Expansion of summary note | portal hypertension (e.g., long-lasting porto-sinusoidal disease), when to start endoscopic surveillance in a given patient, or when to shift from a completely noninvasive assessment to an invasive measurement of HVPG in different clinical scenarios<br/>(e.g., sustained virological response after treatment with direct-acting antivirals).<br/>We would like to acknowledge the commitment and efforts of all the authors<br/>from different disciplines (hepatology, endoscopy, radiology, pathology) and from<br/>the different areas of the world that have contributed to this book. They provide an<br/>outstanding example of what interdisciplinary collaboration can bring into the complex field of hepatology.<br/>We hope that this book will be helpful for hepatologists and physicians interested<br/>in liver diseases in order to select the most appropriate diagnostic methods for their<br/>patients with cirrhosis and/or portal hypertension. |
| 654 ## - SUBJECT ADDED ENTRY--FACETED TOPICAL TERMS | |
| General subdivision | Hepatology |
| 700 ## - ADDED ENTRY--PERSONAL NAME | |
| 9 (RLIN) | 15954 |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | ddc |
| Koha item type | E-BOOKS |
| Withdrawn status | Lost status | Source of classification or shelving scheme | Damaged status | Not for loan | Collection | Home library | Current library | Shelving location | Date acquired | Total checkouts | Barcode | Date last seen | Price effective from | Koha item type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | MWALIMU NYERERE LEARNING RESOURCES CENTRE-CUHAS BUGANDO | 06/23/2021 | EBS5273 | 06/23/2021 | 06/23/2021 | E-BOOKS |